Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation

NCT02511041 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

NIH

Sponsor class

Conditions

PGM3

Interventions

DRUG: N-Acetylglucosamine (GlcNAc)
DRUG: Uridine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)